Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults.
Saved in:
| Title: | Diagnosis and management of complications from the treatment of primary central nervous system tumors in adults. |
|---|---|
| Authors: | Weller M; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Le Rhun E; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland.; Department of Neurosurgery, Clinical Neuroscience Center, University Hospital and University of Zurich, Zurich, Switzerland., Van den Bent M; The Brain Tumour Center at the Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Chang SM; Department of Neurological Surgery, University of California, San Francisco, California, USA., Cloughesy TF; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angeles, California, USA., Goldbrunner R; Center of Neurosurgery, Department of General Neurosurgery, University of Cologne, Cologne, Germany., Hong YK; Brain Tumor Center, Hallym University Sacred Heart Hospital, Anyang, South Korea., Jalali R; Neuro Oncology Cancer Management Team, Apollo Proton Cancer Centre, Chennai, India., Jenkinson MD; Department of Neurosurgery, The Walton Centre NHS Foundation Trust & University of Liverpool, Liverpool, UK., Minniti G; Department of Medicine, Surgery and Neurosciences, University of Siena, Policlinico Le Scotte, Siena, Italy.; IRCCS Neuromed, Pozzilli, IS, Italy., Nagane M; Department of Neurosurgery, Kyorin University Faculty of Medicine, Tokyo, Japan., Razis E; Third Department of Medical Oncology, Hygeia Hospital, Marousi, Athens, Greece., Roth P; Department of Neurology, University Hospital and University of Zurich, Zurich, Switzerland., Rudà R; Division of Neuro-Oncology, Department of Neuroscience, City of Health and Science and University of Turin, Turin, Italy., Tabatabai G; Department of Neurology & Neuro-Oncology, Hertie Institute for Clinical Brain Research, Center for Neurooncology, Comprehensive Cancer Center, German Cancer Consortium (DKTK), Partner site Tübingen, University Hospital Tübingen, Eberhard Karls University Tübingen, Tübingen, Germany., Wen PY; Center for Neuro-oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts, USA., Short SC; Leeds Institute of Medical Research, University of Leeds, Leeds, UK.; Department of Clinical Oncology, Leeds Teaching Hospitals NHS Trust, Leeds, UK., Preusser M; Division of Oncology, Department of Medicine 1, Medical University, Vienna, Austria. |
| Source: | Neuro-oncology [Neuro Oncol] 2023 Jul 06; Vol. 25 (7), pp. 1200-1224. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 100887420 Publication Model: Print Cited Medium: Internet ISSN: 1523-5866 (Electronic) Linking ISSN: 15228517 NLM ISO Abbreviation: Neuro Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
